Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach

被引：22

作者：

Sarkadi, Balazs ^{[1
]}

Saskoi, Eva ^{[2
]}

Butz, Henriett ^{[1
,2
,3
]}

Patocs, Attila ^{[1
,2
,3
]}

机构：

[1] ELKH Hereditary Canc Res Grp, H-1052 Budapest, Hungary

[2] Natl Inst Oncol, Dept Mol Genet, H-1122 Budapest, Hungary

[3] Semmelweis Univ, Dept Lab Med, H-1085 Budapest, Hungary

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 03期

关键词：

pheochromocytoma; paraganglioma; hereditary tumor; susceptibility genes; germline; somatic; metastatic; treatment; personalized medicine; RECEPTOR RADIONUCLIDE THERAPY; FUNCTIONAL IMAGING MODALITIES; GERMLINE MUTATIONS; METASTATIC PHEOCHROMOCYTOMA; SPORADIC PHEOCHROMOCYTOMAS; RET PROTOONCOGENE; HIF2A MUTATIONS; MAX MUTATIONS; EXPRESSION; ACTIVATION;

D O I：

10.3390/ijms23031450

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pheochromocytomas and paragangliomas are the most heritable endocrine tumors. In addition to the inherited mutation other driver mutations have also been identified in tumor tissues. All these genetic alterations are clustered in distinct groups which determine the pathomechanisms. Most of these tumors are benign and their surgical removal will resolve patient management. However, 5-15% of them are malignant and therapeutical possibilities for them are limited. This review provides a brief insight about the tumorigenesis associated with pheochromocytomas/paragangliomas in order to present them as potential therapeutical targets.

引用

页数：17

共 134 条

[1] Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
Alrezk, Rami
Suarez, Andres
Tena, Isabel
Pacak, Karel
[J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
[2] Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression
Alzofon, Nathaniel
Koc, Katrina
Panwell, Kristin
Pozdeyev, Nikita
Marshall, Carrie B.
Albuja-Cruz, Maria
Raeburn, Christopher D.
Nathanson, Katherine L.
Cohen, Debbie L.
Wierman, Margaret E.
Kiseljak-Vassiliades, Katja
Fishbein, Lauren
[J]. MOLECULAR CANCER RESEARCH, 2021, 19 (09) : 1476 - 1485
[3] International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Amar, Laurence
Pacak, Karel
Steichen, Olivier
Akker, Scott A.
Aylwin, Simon J. B.
Baudin, Eric
Buffet, Alexandre
Burnichon, Nelly
Clifton-Bligh, Roderick J.
Dahia, Patricia L. M.
Fassnacht, Martin
Grossman, Ashley B.
Herman, Philippe
Hicks, Rodney J.
Januszewicz, Andrzej
Jimenez, Camilo
Kunst, Henricus P. M.
Lewis, Dylan
Mannelli, Massimo
Naruse, Mitsuhide
Robledo, Mercedes
Taieb, David
Taylor, David R.
Timmers, Henri J. L. M.
Treglia, Giorgio
Tufton, Nicola
Young, William F.
Lenders, Jacques W. M.
Gimenez-Roqueplo, Anne-Paule
Lussey-Lepoutre, Charlotte
[J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (07) : 435 - 444
[4] Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
Andrews, Katrina A.
Ascher, David B.
Pires, Douglas Eduardo Valente
Barnes, Daniel R.
Vialard, Lindsey
Casey, Ruth T.
Bradshaw, Nicola
Adlard, Julian
Aylwin, Simon
Brennan, Paul
Brewer, Carole
Cole, Trevor
Cook, Jackie A.
Davidson, Rosemarie
Donaldson, Alan
Fryer, Alan
Greenhalgh, Lynn
Hodgson, Shirley V.
Irving, Richard
Lalloo, Fiona
McConachie, Michelle
McConnell, Vivienne P. M.
Morrison, Patrick J.
Murday, Victoria
Park, Soo-Mi
Simpson, Helen L.
Snape, Katie
Stewart, Susan
Tomkins, Susan E.
Wallis, Yvonne
Izatt, Louise
Goudie, David
Lindsay, Robert S.
Perry, Colin G.
Woodward, Emma R.
Antoniou, Antonis C.
Maher, Eamonn R.
[J]. JOURNAL OF MEDICAL GENETICS, 2018, 55 (06) : 384 - 394
[5] ASAI N, 1995, MOL CELL BIOL, V15, P1613
[6] Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
Ayala-Ramirez, Montserrat
Feng, Lei
Johnson, Marcella M.
Ejaz, Shamim
Habra, Mouhammed Amir
Rich, Thereasa
Busaidy, Naifa
Cote, Gilbert J.
Perrier, Nancy
Phan, Alexandria
Patel, Shreyaskumar
Waguespack, Steven
Jimenez, Camilo
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) : 717 - 725
[7] THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS
BALLESTER, R
MARCHUK, D
BOGUSKI, M
SAULINO, A
LETCHER, R
WIGLER, M
COLLINS, F
[J]. CELL, 1990, 63 (04) : 851 - 859
[8] Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
Bausch, Birke
Schiavi, Francesca
Ni, Ying
Welander, Jenny
Patocs, Attila
Ngeow, Joanne
Wellner, Ulrich
Malinoc, Angelica
Taschin, Elisa
Barbon, Giovanni
Lanza, Virginia
Soederkvist, Peter
Stenman, Adam
Larsson, Catharina
Svahn, Fredrika
Chen, Jin-Lian
Marquard, Jessica
Fraenkel, Merav
Walter, Martin A.
Peczkowska, Mariola
Prejbisz, Aleksander
Jarzab, Barbara
Hasse-Lazar, Kornelia
Petersenn, Stephan
Moeller, Lars C.
Meyer, Almuth
Reisch, Nicole
Trupka, Arnold
Brase, Christoph
Galiano, Matthias
Preuss, Simon F.
Kwok, Pingling
Lendvai, Nikoletta
Berisha, Gani
Makay, Ozer
Boedeker, Carsten C.
Weryha, Georges
Racz, Karoly
Januszewicz, Andrzej
Walz, Martin K.
Gimm, Oliver
Opocher, Giuseppe
Eng, Charis
Neumann, Hartmut P. H.
[J]. JAMA ONCOLOGY, 2017, 3 (09) : 1204 - 1212
[9] Genetic predisposition to neural crest-derived tumors: revisiting the role of KIF1B
Bauters, Catherine Cardot
Leteurtre, Emmanuelle
Carnaille, Bruno
Do Cao, Christine
Espiard, Stephanie
Penven, Malo
Destailleur, Evelyne
Szuster, Isabelle
Lovecchio, Tonio
Leclerc, Julie
Frenois, Frederic
Esquivel, Emmanuel
Dahia, Patricia L. M.
Ait-Yahya, Emilie
Crepin, Michel
Pigny, Pascal
[J]. ENDOCRINE CONNECTIONS, 2020, 9 (10): : 1042 - 1050
[10] Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations
Baysal, Bora E.
Maher, Eamonn R.
[J]. ENDOCRINE-RELATED CANCER, 2015, 22 (04) : T71 - T82

← 1 2 3 4 5 6 7 8 9 10 →